Maravai Lifesciences Holdings Inc Cl A (MRVI)

$2.07 -0.27 (-11.54%)
Market Cap 578.08M
Revenue (ttm) 259.19M
Net Income (ttm) -144.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -55.89%
Debt to Equity Ratio 0.56
Volume 1,854,880
Avg Vol 1,692,916
Day's Range N/A - N/A
Shares Out 254.66M
Stochastic %K 25%
Beta 0.28
Analysts Sell
Price Target $5.22

Company Profile

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleosid...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 546 0004
Address:
10770 Wateridge Circle, Suite 200, San Diego, United States
ASTANA
ASTANA Jul. 31 at 12:04 PM
$MRVI https://www.fiercepharma.com/pharma/vinay-prasad-departs-fda-amid-conservative-criticism-controversy-over-sarepta-gene-therapy
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 29 at 9:42 PM
$MRVI Brilliant piece that captures MRVI's situation perfectly. So if you want to update your understanding of MRVI or get to know MRVI better, this is essential reading. https://beyondspx.com/article/maravai-lifesciences-building-a-diversified-future-beyond-the-pandemic-peak-nasdaq-mrvi
0 · Reply
michelvd
michelvd Jul. 28 at 6:02 PM
$MRVI New CEO and CFO, it will be going up from here.
0 · Reply
MGeronimo
MGeronimo Jul. 26 at 6:14 PM
$MRVI IN AT 2.69
0 · Reply
Leonardo01
Leonardo01 Jul. 10 at 3:17 PM
$MRVI Its waking up!!
0 · Reply
MadMusk
MadMusk Jul. 2 at 5:47 PM
$MRVI $MRNA $CRSP $PFE
0 · Reply
11thestate
11thestate Jul. 2 at 11:38 AM
$MRVI stockholders filed a claim against Maravai LifeSciences for allegedly misleading investors about its revenue recognition practices and internal controls. You can join this case to be notified about any new information: https://11th.com/cases/maravai-investor-suit
0 · Reply
MadMusk
MadMusk Jul. 1 at 5:22 PM
$MRVI $XBI $MRNA $CRSP
0 · Reply
IntrinSick008
IntrinSick008 Jun. 12 at 1:17 PM
$MRVI Obviously this one’s been left for dead, but what do ppl make of the new CEO appt? Trey wasn’t there that long and BB seems to have an expertise at prettying up the pigs for slaughter…
2 · Reply
DARKP00L
DARKP00L Jun. 3 at 2:03 PM
$MRVI 10:02 on Jun. 03 2025 Maravai LifeSciences' TriLink Signs Non-Exclusive License And Supply Agreement With Quantoom Biosciences For CleanCap mRNA Capping Technology #tradeideas
0 · Reply
Latest News on MRVI
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

Jul 28, 2025, 5:08 PM EDT - 8 days ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences

Jul 2, 2025, 8:49 AM EDT - 5 weeks ago

Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences

APP QUBT SWKS

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Jun 25, 2025, 4:01 PM EDT - 5 weeks ago

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

Jun 17, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Jun 15, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

Jun 12, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Jun 10, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect

Jun 8, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Jun 5, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 2 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

May 29, 2025, 10:05 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 2 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

May 25, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

May 22, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:22 PM EDT - 2 months ago

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

Maravai LifeSciencesReleases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 2 months ago

Maravai LifeSciencesReleases 2024 Sustainability Report

Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 2 months ago

Maravai LifeSciences Releases 2024 Sustainability Report

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

May 20, 2025, 8:00 AM EDT - 2 months ago

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

May 18, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 15, 2025, 10:00 AM EDT - 2 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

May 13, 2025, 1:29 PM EDT - 3 months ago

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

May 13, 2025, 12:03 AM EDT - 3 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

Maravai Lifesciences Reports First Quarter 2025 Financial Results

May 12, 2025, 4:06 PM EDT - 3 months ago

Maravai Lifesciences Reports First Quarter 2025 Financial Results

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

May 5, 2025, 5:47 AM EDT - 3 months ago

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

May 1, 2025, 7:30 AM EDT - 3 months ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 19, 2025, 7:36 AM EDT - 3 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman

Apr 16, 2025, 6:10 PM EDT - 3 months ago

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

Apr 15, 2025, 6:00 PM EDT - 4 months ago

Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations - Hagens Berman

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Apr 9, 2025, 11:23 AM EDT - 4 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

ASTANA
ASTANA Jul. 31 at 12:04 PM
$MRVI https://www.fiercepharma.com/pharma/vinay-prasad-departs-fda-amid-conservative-criticism-controversy-over-sarepta-gene-therapy
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 29 at 9:42 PM
$MRVI Brilliant piece that captures MRVI's situation perfectly. So if you want to update your understanding of MRVI or get to know MRVI better, this is essential reading. https://beyondspx.com/article/maravai-lifesciences-building-a-diversified-future-beyond-the-pandemic-peak-nasdaq-mrvi
0 · Reply
michelvd
michelvd Jul. 28 at 6:02 PM
$MRVI New CEO and CFO, it will be going up from here.
0 · Reply
MGeronimo
MGeronimo Jul. 26 at 6:14 PM
$MRVI IN AT 2.69
0 · Reply
Leonardo01
Leonardo01 Jul. 10 at 3:17 PM
$MRVI Its waking up!!
0 · Reply
MadMusk
MadMusk Jul. 2 at 5:47 PM
$MRVI $MRNA $CRSP $PFE
0 · Reply
11thestate
11thestate Jul. 2 at 11:38 AM
$MRVI stockholders filed a claim against Maravai LifeSciences for allegedly misleading investors about its revenue recognition practices and internal controls. You can join this case to be notified about any new information: https://11th.com/cases/maravai-investor-suit
0 · Reply
MadMusk
MadMusk Jul. 1 at 5:22 PM
$MRVI $XBI $MRNA $CRSP
0 · Reply
IntrinSick008
IntrinSick008 Jun. 12 at 1:17 PM
$MRVI Obviously this one’s been left for dead, but what do ppl make of the new CEO appt? Trey wasn’t there that long and BB seems to have an expertise at prettying up the pigs for slaughter…
2 · Reply
DARKP00L
DARKP00L Jun. 3 at 2:03 PM
$MRVI 10:02 on Jun. 03 2025 Maravai LifeSciences' TriLink Signs Non-Exclusive License And Supply Agreement With Quantoom Biosciences For CleanCap mRNA Capping Technology #tradeideas
0 · Reply
Jonny52677
Jonny52677 May. 30 at 4:00 PM
$SOXL $MRVI how blessed are we here. Like think out loud, go take a look at the daily chart, and look at how bullish this movement has been. Ask yourself if you think ships are going to be less prevalent or more prevalent in the future. I am in the camp of thinking that ship demand or continue to grow year over year. this is just the beginning. Don’t look at the day-to-day action. Six months from now we could be on a massive ball run and this could be well over $40.
0 · Reply
RunnerSignals
RunnerSignals May. 29 at 8:31 PM
gap down at open, but these champs didn’t quit! $VERV $MRVI $OLPX surged back strong to close up big proof that comebacks are real
0 · Reply
ASTANA
ASTANA May. 29 at 3:47 PM
$MRVI https://investors.maravai.com/news-events/press-releases/detail/112/trilink-biotechnologies-debuts-its-first-mrna-synthesis-kit-with-cleancap-capping-technology-celebrates-launch-with-kit-donations-to-top-academic-institutions
0 · Reply
ASTANA
ASTANA May. 20 at 3:25 PM
$MRVI $MRNA 🚀👀
1 · Reply
alexpitti
alexpitti May. 15 at 11:14 PM
$MRVI this is an unmitigated disaster of a company
1 · Reply
Estimize
Estimize May. 14 at 8:00 PM
Wall St is expecting -0.07 EPS for $MRVI Q2 [Reporting 08/12 AMC] http://www.estimize.com/intro/mrvi?chart=historical&metric_name=eps&utm_c
0 · Reply
JarvisFlow
JarvisFlow May. 13 at 5:12 PM
Craig-Hallum has adjusted their stance on Maravai LifeSciences ( $MRVI ), setting the rating to Buy with a target price of 12 → 10.
0 · Reply
JarvisFlow
JarvisFlow May. 13 at 1:00 PM
Baird has adjusted their stance on Maravai LifeSciences ( $MRVI ), setting the rating to Neutral with a target price of 3 → 2.
0 · Reply
dosl
dosl May. 13 at 2:23 AM
$MRVI What do you think about earnings? I think the company wanted to appeal that there was little impact from tariffs, and other than that, there didn't seem to be anything special.
1 · Reply
DonCorleone77
DonCorleone77 May. 12 at 8:32 PM
$MRVI Maravai Lifesciences sees FY25 revenue $185M-$205M, consensus $192.75M Maravai's revenue guidance for the full year 2025 is based on expectations for its existing base business and does not include revenue, if any, from high-volume CleanCap orders for commercial phase vaccine programs, or potential new acquisitions, if any, or items that have not yet been identified or quantified.
0 · Reply
DonCorleone77
DonCorleone77 May. 12 at 8:32 PM
$MRVI Maravai Lifesciences reports Q1 adjusted EPS (8c), consensus (7c) Reports Q1 revenue $46.9M, consensus $44.01M. "Our first quarter revenue exceeded our guidance range, and our base business, which excludes revenue from high-volume CleanCap(R) for commercial vaccine programs, grew more than $4 million compared to the fourth quarter of 2024, reflecting solid execution and momentum across the business," said Trey Martin, CEO, Maravai LifeSciences. "Our team remains committed to our return-to-growth strategy amid a dynamic and shifting macroeconomic environment. We believe our customer focus, our differentiated technologies and GMP services supporting clients from discovery through commercialization give us the best position to continue navigating the evolving landscape and drive long-term value for Maravai."
0 · Reply
Olddrache
Olddrache May. 12 at 4:52 PM
$MRVI Expected Move 33.3%
0 · Reply